Wei Pan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei Pan has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Na Li
College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, P. R. China
135 shared publications - Bo Tang
Shandong Normal University
134 shared publications - Peng Gao
College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science, Shandong Normal University, Jinan 250014, P. R. China
30 shared publications Yanhua Li
Shandong Normal University
20 shared publications- Yuanyuan Chen
College of Chemistry
16 shared publications Xiuyan Wan
College of Chemistry, Chemical Engineering and Materials Science, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Institute of Molecular and Nano Science
15 shared publications
Latest Publications
- 22 October 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (83) , 20965-20968
A tumor-triggered assembly–disassembly photothermal agent enables HSP70 targeting for enhanced mild photothermal therapy
A tumor-responsive photothermal system (R-Cy-PES) prolongs circulation and promotes accumulation, while enabling HSP70 inhibition and reverse thermoresistance, achieving tumor suppression.
- 22 October 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (83) , 20965-20968
A tumor-triggered assembly–disassembly photothermal agent enables HSP70 targeting for enhanced mild photothermal therapy
A tumor-responsive photothermal system (R-Cy-PES) prolongs circulation and promotes accumulation, while enabling HSP70 inhibition and reverse thermoresistance, achieving tumor suppression.
- 8 October 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (79) , 19840-19844
A steric hindrance-regulated autocatalytic CRISPR/Cas12a system for direct and amplification-free microRNA detection
An overhang blocker autocatalytic system was developed for CRISPR/Cas12a signal amplification. miRNA-triggered recombination initiates Cas12a autocatalysis, relieves steric hindrance, and generates exponential signals for sensitive miRNA detection.
- 8 October 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (79) , 19840-19844
A steric hindrance-regulated autocatalytic CRISPR/Cas12a system for direct and amplification-free microRNA detection
An overhang blocker autocatalytic system was developed for CRISPR/Cas12a signal amplification. miRNA-triggered recombination initiates Cas12a autocatalysis, relieves steric hindrance, and generates exponential signals for sensitive miRNA detection.
- 24 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (75) , 18797-18801
A TrxR2-targeted photosensitizer for controlled mitochondrial protein degradation and pyroptosis activation
A TrxR2-targeted photosensitizer was designed and synthesized to covalently bind TrxR2 and in situ generate ROS for controlled mitochondrial protein degradation and pyroptosis activation.
- 24 September 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (75) , 18797-18801
A TrxR2-targeted photosensitizer for controlled mitochondrial protein degradation and pyroptosis activation
A TrxR2-targeted photosensitizer was designed and synthesized to covalently bind TrxR2 and in situ generate ROS for controlled mitochondrial protein degradation and pyroptosis activation.
- 25 August 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (66) , 16351-16366
Amplification-free CRISPR/Cas biosensors for point-of-care nucleic acid detection: recent advances and future perspectives
The latest advances and perspectives in the development of amplification-free CRISPR/Cas biosensors for point-of-care testing of nucleic acid targets.
- 25 August 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (66) , 16351-16366
Amplification-free CRISPR/Cas biosensors for point-of-care nucleic acid detection: recent advances and future perspectives
The latest advances and perspectives in the development of amplification-free CRISPR/Cas biosensors for point-of-care testing of nucleic acid targets.
- 21 August 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (34) , 23992-24003
An “Oxidative Stress Clock” Nanoprobe Reveals the Therapeutic Time Window for Antioxidant Intervention in Atherosclerosis
The antioxidant treatment for atherosclerosis has presented a paradox: theoretically feasible but clinically ineffective. In this study, we developed an “oxidative stress clock” nanoprobe to dynamically monitor oxidative stress at different stages of atherosclerosis, thereby dissecting the optimal time window for antioxidant intervention. This probe could simultaneously and specifically recognize hydrogen peroxide, protein sulfenylation, and protein phosphorylation in vitro and in vivo, enabling accurate mapping of the evolution of oxidative stress during disease progression. Using this probe, we discovered that the effective window for antioxidant intervention is limited to the stage of reversible protein oxidative modification. However, clinical ultrasound imaging identifies plaques well after this critical window, which directly contributes to the clinical failure of antioxidant therapy. Furthermore, the underlying molecular mechanism driving oxidative stress-mediated atherosclerosis progression (ox-LDL→H2O2→EGFR/Src/PTP1B-SOH→p-MAPK→atherosclerosis) was uncovered.
- 21 August 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (34) , 23992-24003
An “Oxidative Stress Clock” Nanoprobe Reveals the Therapeutic Time Window for Antioxidant Intervention in Atherosclerosis
The antioxidant treatment for atherosclerosis has presented a paradox: theoretically feasible but clinically ineffective. In this study, we developed an “oxidative stress clock” nanoprobe to dynamically monitor oxidative stress at different stages of atherosclerosis, thereby dissecting the optimal time window for antioxidant intervention. This probe could simultaneously and specifically recognize hydrogen peroxide, protein sulfenylation, and protein phosphorylation in vitro and in vivo, enabling accurate mapping of the evolution of oxidative stress during disease progression. Using this probe, we discovered that the effective window for antioxidant intervention is limited to the stage of reversible protein oxidative modification. However, clinical ultrasound imaging identifies plaques well after this critical window, which directly contributes to the clinical failure of antioxidant therapy. Furthermore, the underlying molecular mechanism driving oxidative stress-mediated atherosclerosis progression (ox-LDL→H2O2→EGFR/Src/PTP1B-SOH→p-MAPK→atherosclerosis) was uncovered.
- 31 July 2026
- Published by ELS Publishing Co. Limited in Life Analysis
- Vol. 1 (1) , 1-55
Targets and strategies for cancer diagnosis and imaging
Cancer diagnostic imaging is undergoing a fundamental transition from conventional anatomical visualization to molecular-targeted and functionally driven profiling of tumor biology. Next-generation imaging no longer merely detects morphological lesions, but decodes the dynamic biological states underlying tumor initiation, progression, immune remodeling, metabolic reprogramming, and therapeutic response. Imaging targets with high specificity, biological accessibility, and functional relevance are primary drivers of this technological transition. Current cancer imaging targets can be categorized into three spatial layers: extracellular biomarkers, membrane-associated targets, and intracellular biomarkers. Progress in nanotechnology, molecular engineering, bioorthogonal chemistry, and artificial intelligence (AI) has greatly facilitated the construction of multimodal, multi-target, and intelligent imaging systems. Nevertheless, clinical translation still faces prominent obstacles, including tumor heterogeneity, temporal biomarker fluctuation, limited tissue penetration, nonspecific background signals from off-target activation, and translational gaps. This review systematically classifies imaging targets based on their spatial distribution and biological function, summarizes the latest advances in cancer diagnosis and imaging, and discusses emerging research directions and future prospects for next-generation precision oncology.
- 31 July 2026
- Published by ELS Publishing Co. Limited in Life Analysis
- Vol. 1 (1) , 1-55
Targets and strategies for cancer diagnosis and imaging
Cancer diagnostic imaging is undergoing a fundamental transition from conventional anatomical visualization to molecular-targeted and functionally driven profiling of tumor biology. Next-generation imaging no longer merely detects morphological lesions, but decodes the dynamic biological states underlying tumor initiation, progression, immune remodeling, metabolic reprogramming, and therapeutic response. Imaging targets with high specificity, biological accessibility, and functional relevance are primary drivers of this technological transition. Current cancer imaging targets can be categorized into three spatial layers: extracellular biomarkers, membrane-associated targets, and intracellular biomarkers. Progress in nanotechnology, molecular engineering, bioorthogonal chemistry, and artificial intelligence (AI) has greatly facilitated the construction of multimodal, multi-target, and intelligent imaging systems. Nevertheless, clinical translation still faces prominent obstacles, including tumor heterogeneity, temporal biomarker fluctuation, limited tissue penetration, nonspecific background signals from off-target activation, and translational gaps. This review systematically classifies imaging targets based on their spatial distribution and biological function, summarizes the latest advances in cancer diagnosis and imaging, and discusses emerging research directions and future prospects for next-generation precision oncology.
- 3 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (27) , 37518-37528
DNAzyme-Enhanced CRISPR/Cas12a Cascade Enables Isothermal, One-Pot RNA Diagnostics
While integrating DNAzymes with Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas systems offers a promising route to enhance CRISPR/Cas12a-based molecular diagnosis via enzyme-coupled cascade amplification, their implementation in simple, specific, and sensitive nucleic acid detection remains challenging, largely due to reliance on complex, multistep workflows. Here, we report an RNA-triggered DNAzyme circuit integrated with CRISPR/Cas12a that serves as a universal nucleic acid preamplifier, enabling one-pot and homogeneous detection. The catalytic activity of DNAzyme, initially suppressed by a complementary blocker strand, was restored upon the recognition of the target analyte. The activated DNAzyme then cleaved a hairpin-shaped substrate, liberating multiple activators that triggered a secondary CRISPR/Cas amplification reaction. This cascade generated a visible red band signal on a lateral flow assay via the collateral cleavage of a reporter. By employing the DNAzyme as a signal amplifier, the system efficiently converted a single RNA molecule into numerous initiators, breaking the one-to-one activation relationship between the target and Cas12a ribonucleoprotein and thereby greatly enhancing the detection sensitivity. Additionally, the system exhibited high programmability and universality, as a biosensor for a given target could be easily constructed by simply customizing the corresponding region of the blocker strand that is complementary to the target sequence. This integrated cascade system enables efficient signal amplification within a simple one-pot format and holds significant promise for practical applications.
- 3 July 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (27) , 37518-37528
DNAzyme-Enhanced CRISPR/Cas12a Cascade Enables Isothermal, One-Pot RNA Diagnostics
While integrating DNAzymes with Clustered regularly interspaced short palindromic repeat (CRISPR)/Cas systems offers a promising route to enhance CRISPR/Cas12a-based molecular diagnosis via enzyme-coupled cascade amplification, their implementation in simple, specific, and sensitive nucleic acid detection remains challenging, largely due to reliance on complex, multistep workflows. Here, we report an RNA-triggered DNAzyme circuit integrated with CRISPR/Cas12a that serves as a universal nucleic acid preamplifier, enabling one-pot and homogeneous detection. The catalytic activity of DNAzyme, initially suppressed by a complementary blocker strand, was restored upon the recognition of the target analyte. The activated DNAzyme then cleaved a hairpin-shaped substrate, liberating multiple activators that triggered a secondary CRISPR/Cas amplification reaction. This cascade generated a visible red band signal on a lateral flow assay via the collateral cleavage of a reporter. By employing the DNAzyme as a signal amplifier, the system efficiently converted a single RNA molecule into numerous initiators, breaking the one-to-one activation relationship between the target and Cas12a ribonucleoprotein and thereby greatly enhancing the detection sensitivity. Additionally, the system exhibited high programmability and universality, as a biosensor for a given target could be easily constructed by simply customizing the corresponding region of the blocker strand that is complementary to the target sequence. This integrated cascade system enables efficient signal amplification within a simple one-pot format and holds significant promise for practical applications.
- 2 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (25) , 6731-6735
DHA/Fe 2+ -doped porphyrin COFs enable ROS-amplified multimodal tumor therapy
A porphyrin-based covalent organic framework system doped with Fe2+ and dihydroartemisinin (DHA) has been developed for enhanced antitumor therapy. This platform enables coordinated generation of reactive oxygen species (ROS) including DHA-derived radicals, Fe2+-driven chemodynamic therapy (CDT), and porphyrin-mediated photodynamic therapy (PDT), which collectively amplify oxidative stress and significantly improve therapeutic efficacy.
- 2 March 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (25) , 6731-6735
DHA/Fe 2+ -doped porphyrin COFs enable ROS-amplified multimodal tumor therapy
A porphyrin-based covalent organic framework system doped with Fe2+ and dihydroartemisinin (DHA) has been developed for enhanced antitumor therapy. This platform enables coordinated generation of reactive oxygen species (ROS) including DHA-derived radicals, Fe2+-driven chemodynamic therapy (CDT), and porphyrin-mediated photodynamic therapy (PDT), which collectively amplify oxidative stress and significantly improve therapeutic efficacy.
- 1 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (5) , 3501-3509
Framework Doping Enhances COF-DNA Nanoplatforms for Dual RNA Imaging and Phototherapy
DNA-engineered covalent organic frameworks (COFs) hold great promise for cancer theranostics. However, regulating the interaction between COFs and functional DNAs remains a significant challenge, despite its crucial role in ensuring the theranostic performance. In this study, we present a framework doping strategy that simultaneously optimizes the diagnostic imaging and phototherapeutic effects of the COF-DNA nanosystems. In situ doping of porphyrin allows the photocatalytic generation of reactive oxygen species (ROS) by COF nanoparticles and facilitates the adsorption and quenching of fluorescent single-stranded DNA (ssDNA). This enabled the construction of a high-performance COF-DNA nanosystem for RNA-imaging guided phototherapy: the system restored intense fluorescence signals in response to cancer-associated mRNA and miRNA and generated abundant ROS upon laser irradiation, thereby simultaneously lighting up and killing cancer cells. The developed framework doping strategy provides valuable insights into regulating COF-DNA interactions and constructing high-performance theranostic nanosystems.
- 1 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (5) , 3501-3509
Framework Doping Enhances COF-DNA Nanoplatforms for Dual RNA Imaging and Phototherapy
DNA-engineered covalent organic frameworks (COFs) hold great promise for cancer theranostics. However, regulating the interaction between COFs and functional DNAs remains a significant challenge, despite its crucial role in ensuring the theranostic performance. In this study, we present a framework doping strategy that simultaneously optimizes the diagnostic imaging and phototherapeutic effects of the COF-DNA nanosystems. In situ doping of porphyrin allows the photocatalytic generation of reactive oxygen species (ROS) by COF nanoparticles and facilitates the adsorption and quenching of fluorescent single-stranded DNA (ssDNA). This enabled the construction of a high-performance COF-DNA nanosystem for RNA-imaging guided phototherapy: the system restored intense fluorescence signals in response to cancer-associated mRNA and miRNA and generated abundant ROS upon laser irradiation, thereby simultaneously lighting up and killing cancer cells. The developed framework doping strategy provides valuable insights into regulating COF-DNA interactions and constructing high-performance theranostic nanosystems.
- 13 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (11) , 3602-3605
A dual-strike strategy against glycolytic and mitochondrial metabolism for potentiated mild photothermal therapy
A dual-strike strategy was developed to synergistically inhibit glycolysis and disrupt mitochondrial function, thereby enhancing mild photothermal therapy.
- 13 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (11) , 3602-3605
A dual-strike strategy against glycolytic and mitochondrial metabolism for potentiated mild photothermal therapy
A dual-strike strategy was developed to synergistically inhibit glycolysis and disrupt mitochondrial function, thereby enhancing mild photothermal therapy.